SCHEMBL16970683

SCHEMBL16970683

Cc1ccc(N(CCO)CCO)cc1C[C@H](CC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AAK1 Q2M2I8 3/20 0.36
▸ ATM Q13315 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.34
▸ ABCB1 P08183 1/20 0.34
▸ PAX8 Q06710 1/20 0.33
▸ GAA P10253 3/20 0.33
▸ PKM P14618 2/20 0.33
▸ HTT P42858 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ USP2 O75604 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ XBP1 P17861 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ MAPT P10636 4/20 0.32
▸ HPGD P15428 2/20 0.32
▸ TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28515394 1.00 AAK1 (0.36) AAK1ATMCYP2D6ALDH1A1ABCB1
SCHEMBL28518467 0.95 LMNA (0.34) AAK1ATMCYP2D6ALDH1A1ABCB1
SCHEMBL16974968 0.92 ATM (0.38) AAK1ATMALDH1A1GAAPKM
SCHEMBL18427995 0.92 ATM (0.38) AAK1ATMALDH1A1GAAPKM
SCHEMBL16970635 0.91 LMNA (0.36) AAK1ATMCYP2D6ALDH1A1ABCB1
SCHEMBL16970593 0.91 AAK1 (0.38) AAK1ATMCYP2D6ALDH1A1ABCB1
SCHEMBL28524688 0.91 AAK1 (0.38) AAK1ATMCYP2D6ALDH1A1ABCB1
SCHEMBL28524714 0.91 LMNA (0.36) AAK1ATMCYP2D6ALDH1A1ABCB1
SCHEMBL28520990 0.91 LMNA (0.36) AAK1ATMCYP2D6ALDH1A1ABCB1
SCHEMBL28514892 0.88 CACNA1B (0.37) AAK1ATMCYP2D6ABCB1PAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9394237-B2 β-substituted β-amino acids and analogs as chemotherapeutic agents QUADRIGA BIOSCIENCES, INC. (US) 2016-07-19 — — US disclosed
US-20150218086-A1 BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS QUADRIGA BIOSCIENCES, INC. 2015-08-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150218086-A1 BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS SLC7A1, SLC3A2, SLC1A5 AAK1 1370/4885ATM 3249/4885CYP2D6 2253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback